BioStem Technologies, Inc. — Form S-1
Filed October 2, 2026 · analyzed by the Registration Agent
S-1
— Neutral
significance 72/100
What the filing says
BioStem Technologies filed an S-1 Registration Statement on October 2, 2026, to register 2,224,270 shares for resale by selling stockholders. The securities consist of 735,296 direct shares and 1,488,974 warrant shares (Series A, Series B, and placement agent warrants) issued pursuant to a securities purchase agreement dated September 29, 2026, and an engagement letter dated September 19, 2026. No purchase price or investor names are disclosed in this legal opinion exhibit.
Why this rating
PIPE financing of ~2.2M shares is material relative to $48.8M asset base; registration for resale is routine S-1 process but capital raise scale matters. No price/dilution % stated in filing—cannot calculate exact impact.
Price action (we called it neutral)
before filing · preread $2.61 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.